In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 230 for your search:
Drug:  lenalidomide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0210051, CELGENE-CDC-501-MEL-001, MSKCC-03026, NCT00060281

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-DLC-001, NCT01197560

3.

Phase: Phase III, Phase II
Type: Tissue collection/Repository, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00242, SWOG-S1117, CDR0000723909, S1117, U10CA032102, U10CA180888, NCT01522976

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000306449, U10CA032102, S0232, SWOG-S0232, NCT00064038

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MEL-002, NCT00057616

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2003-35, NCT00093028

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2009-00439, CDR0000434845, CALGB 100104/ECOG 100104, CALGB-100104, U10CA031946, P30CA014236, ECOG-CALGB-100104, NCT00114101

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MDS-004, 2005-000454-73, NCT00179621

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-015, 2006-001865-41, NCT00405756

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 0400401, French PHRC, NCT00430365

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-018, 2006-002517-12, NCT00420849

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-000649-36, QUIREDEX, NCT00480363

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00521, CDR0000561758, ECOG-E1A05, E1A05, U10CA021115, U10CA180820, NCT00522392

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: RV-MM-PI-209, NCT00551928

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00522, CDR0000583984, ECOG-E1A06, E1A06, U10CA180820, U10CA021115, NCT00602641

16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00798, SWOG-S0777, CDR0000590321, S0777, U10CA032102, NCT00644228

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-020, 2007-004823-39, NCT00689936

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-009, NCT00056160

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-010, NCT00424047

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and ovr
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-CLL-008, 2008-003079-32, NCT00910910

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MM-022, NCT00928486

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03150, CDR0000404161, E4A03, U10CA021115, U10CA180820, ECOG-E4A03, NCT00098475

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-PC-002, EudraCT Number 2008-007969-23, NCT00988208

24.

Phase: Phase III
Type: Health services research, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MDS-005, NCT01029262

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PX-171-009, NCT01080391
1     
New Search